AN IN VITRO COMPARISON OF AZACITIDINE AND DECITABINE ACTIVITIES IN ACUTE MYELOID LEUKEMIA

被引：0
|
作者：
Hollenbach, P. [1 ]
Nguyen, A. [1 ]
Brady, H. [1 ]
Heise, C. [1 ]
MacBeth, K. [1 ]
机构：
[1] Celgene, San Francisco, CA USA
来源：
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL | 2009年 / 94卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1371
引用
收藏
页码：539 / 539
页数：1
相关论文
共 50 条
  • [31] Updated Safety and Efficacy of Venetoclax with Decitabine or Azacitidine in Treatment-Naive, Elderly Patients with Acute Myeloid Leukemia
    DiNardo, Courtney D.
    Pollyea, Daniel A.
    Jonas, Brian A.
    Konopleva, Marina
    Pullarkat, Vinod
    Wei, Andrew
    Kantarjian, Hagop M.
    Pigneux, Arnaud
    Recher, Christian
    Seymour, John F.
    Dunbar, Martin
    Xu, Tu
    Mabry, Mack
    Potluri, Jalaja
    Pratz, Keith
    Letai, Anthony
    BLOOD, 2017, 130
  • [32] Efficacy and safety of venetoclax in combination with azacitidine or decitabine in an outpatient setting in patients with untreated acute myeloid leukemia.
    Manda, Sudhir
    Anz, Bertrand Marquess
    Benton, Christopher
    Broun, E. Randolph
    Yimer, Habte Aragaw
    Melear, Jason M.
    Cruz, Jose C.
    Fanning, Suzanne
    Sharman, Jeff Porter
    Kang, Kingston
    Svensson, Anders
    Pai, Madhavi
    Geils, George F.
    Renshaw, John Scott
    Donnellan, William Bruce
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [33] A phase 3b study of venetoclax and azacitidine or decitabine in an outpatient setting in patients with acute myeloid leukemia
    Manda, Sudhir
    Anz III, Bertrand M.
    Benton, Christopher
    Broun, E. Randolph
    Yimer, Habte A.
    Renshaw, John S.
    Geils Jr, George
    Berdeja, Jesus
    Cruz, Jose
    Melear, Jason M.
    Fanning, Suzanne
    Fletcher, Luke
    Li, Yukun
    Duan, Yinghui
    Werner, Michael E.
    Potluri, Jalaja
    Pai, Madhavi V.
    Donnellan, William B.
    HEMATOLOGICAL ONCOLOGY, 2024, 42 (03)
  • [34] A real-world study of infectious complications of venetoclax combined with decitabine or azacitidine in adult acute myeloid leukemia
    Zhu, Li-xia
    Chen, Rong-rong
    Wang, Lu-lu
    Sun, Jia-nai
    Zhou, De
    Li, Li
    Qian, Jie-jing
    Zhang, Yi
    Tong, Hong-yan
    Yu, Wen-juan
    Meng, Hai-tao
    Mai, Wen-yuan
    Xie, Wan-zhuo
    Jin, Jie
    Ye, Xiu-jin
    Zhu, Hong-hu
    SUPPORTIVE CARE IN CANCER, 2022, 30 (08) : 7031 - 7038
  • [35] Azacitidine in adult patients with acute myeloid leukemia
    Schuh, Andre C.
    Doehner, Hartmut
    Pleyer, Lisa
    Seymour, John F.
    Fenaux, Pierre
    Dombret, Herve
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2017, 116 : 159 - 177
  • [36] AZACITIDINE FOR ACUTE MYELOID LEUKEMIA AND MYELODYSPLASTIC SYNDROME
    Gritsaev, S., V
    Martynkevich, I. S.
    Kostroma, I. I.
    GEMATOLOGIYA I TRANSFUZIOLOGIYA, 2012, 57 (01): : 23 - 29
  • [37] Oral Azacitidine Maintenance for Acute Myeloid Leukemia
    Perissinotti, Anthony J.
    Benitez, Lydia L.
    Marini, Bernard L.
    NEW ENGLAND JOURNAL OF MEDICINE, 2021, 384 (13):
  • [38] Azacitidine for the treatment of patients with acute myeloid leukemia
    Maurillo, Luca
    Venditti, Adriano
    Spagnoli, Alessandra
    Gaidano, Gianluca
    Ferrero, Dario
    Oliva, Esther
    Lunghi, Monia
    D'Arco, Alfonso M.
    Levis, Alessandro
    Pastore, Domenico
    Di Renzo, Nicola
    Santagostino, Alberto
    Pavone, Vincenzo
    Buccisano, Francesco
    Musto, Pellegrino
    CANCER, 2012, 118 (04) : 1014 - 1022
  • [39] A Case of Leukemia Cutis with Acute Myeloid Leukemia on Azacitidine Therapy
    Kara, Asude
    Belli, Asli Akin
    Karakus, Volkan
    Dere, Yelda
    Kurtoglu, Erdal
    TURKISH JOURNAL OF HEMATOLOGY, 2017, 34 (02) : 192 - 193
  • [40] Acquired resistance to venetoclax plus azacitidine in acute myeloid leukemia: In vitro models and mechanisms
    Carter, Jenna L.
    Su, Yongwei
    Qiao, Xinan
    Zhao, Jianlei
    Wang, Guan
    Howard, Mackenzie
    Edwards, Holly
    Bao, Xun
    Li, Jing
    Huettemann, Maik
    Yang, Jay
    Taub, Jeffrey W.
    Ge, Yubin
    BIOCHEMICAL PHARMACOLOGY, 2023, 216
12345